Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report

Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report·Investor's Business Daily
In this article:

Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but Abbott stock slipped.

Advertisement